No Detail Found!

Development and Quality evaluation of sustained release pellets of eperisone HCl

Author(s)
Syed Hameez Jawed Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Iyad Naeem Muhammad Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Faiza Qazi Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Muhammad Harris Shoaib Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi,Karachi,Pakistan
Hafiz Muhammad Arshad Department of Pharmaceutics, Dow College of Pharmacy,DUHS, Karachi,Pakistan
Tuba Siddiqui Department of Pharmaceutics, Faculty of Pharmacy, Federal Urdu University of Arts, Science and Technology,Karachi,
Abstract
The objective was to develop eperisone HCl sustained-release pellets through extrusion spheronization technique and to determine the influence of different hydrophobic (polymeric based and wax-based) and hydrophilic (polymeric based) matrix former on the release of eperisone HCl (BCS class I drug) and on pellet sphericity. The pellet formulations consisted of different hydrophobic and hydrophilic matrix formers like HPMC K4M (10-20%) HPMC K15M (10%), EC (7cps) (10-20%), Carnauba wax (10-20%), Compritol ATO 888 (10-20%), Glyceryl monostearate (10%), lactose and microcrystalline cellulose. The initial burst release of the drug from matrix pellet formulations was effectively controlled by coating with 5% EC (ethylcellulose) dispersion. The dissolution profile and drug release kinetics of coated pellet formulations were determined at both acidic and basic pH medium. SEM (Scanning electron microscope) technique was used to determine the surface morphology and cross-section of F5 and F7 pellet formulation. The mechanism of drug release of coated formulation followed non-Fickian diffusion. FTIR spectroscopy was conducted and no drug and excipients interaction was observed. The results had shown that optimized coated formulation was F5 and F7 which effectively extend the drug release for 12 hours.
Publication Details
Page(s) 225-235
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP1, Year: 2021

Request the full text from PASTIC

Keywords
Eperisone Hydrochloride, Sustained release, polymers, matrix formers, extrusion spheronization
References
Ahmed K,Shoaib MH,Yousuf RI,Siddiqui F,Qazi F,Iftikhar J,Ahmed FR,Nasiri MI .1867 .Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LCESI-MS/MS method. Sci. Rep, 10(1) : .
Akhgari A,Abbaspour MR,Pirmoradi S MR .2011 .Preparation and evaluation of pellets using acacia and tragacanth by extrusion-spheronization. DARU J. Pharm. Sci., 19(6) : 417.
Anepu S,Duppala L,Pratyusha P .2015 .Development of hydrophobic carriers based tablets for sustained release of verapamil. J. Appl. Pharm. Sci., 12(5) : 125-134.
Ansari I,Bhusari S,Chaudhary A,Shrangare G .2020 .Formulation and evaluation of sustained release pellets of zidovudine by using extrusion and spheronization technique. Asian J. Pharm. Sci., 10(4) : 241-247.
Becker K,Salar-Behzadi S,Zimmer A .2015 .Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharm. Res., 32(5) : 1519-1545.
Beltrame A,Grangiè S,Guerra L S .2008 .Clinical experience with eperisone in the treatment of acute low back pain. Minerva Med, 99(4) : 347-352.
Bose K .1999 .The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial. Methods Find Exp. Clin. Pharmacol, 21(3) : 209-214.
Bresolin N,Zucca C .2009 .Efficacy and tolerability of eperisone and baclofen in spastic palsy: A double-blind randomized trial. Adv. Ther., 26(5) : 563.
Cabitza P and Randelli P .2008 .Efficacy and safety of eperisone in patients with low back pain: A double blind randomized study. Eur. Rev. Med, 12(4) : 229-235.
Rohera Chatlapalli R,BD Chatlapalli R .1998 .Physical characterization of HPMC and HEC and investigation of their use as pelletization aids. Int. J. Pharm., 161(2) : 179-193.
Cheboyina S,Chambliss WG,Wyandt CM .2004 .A novel freeze pelletization technique for preparing matrix pellets. Pharm. Technol. Int., 28(10) : 98-110.
Cheboyina S,Wyandt CM .2008 .Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique: I. Formulation and process variables affecting pellet characteristics. Int. J. Pharm., 359(1-2) : 158-166.
Chhipa P,Pethe AM,Upadhyay S,Tekade A .2009 .Formulation optimization of sustained release pellets of itopride hydrochloride using different polymers. J. Pharm. Res., 2(8) : 1404-1408.
Dassanayake LSK,Kodali DR,Ueno S,Sato K S .2009 .Physical properties of rice bran wax in bulk and organogels. J. Am. Oil Chem. Soc., 86(12) : 1163.
Dukic-Ott A,Remon JP,Foreman P,Vervaet C,Pharm C .2007 .Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/ spheronisation. , 67(3) : 715-724.
Enayatifard R,Saeedi M,Akbari J,Tabatabaee YH .2009 .Effect of hydroxypropyl methylcellulose and ethyl cellulose content on release profile and kinetics of diltiazem HCl from matrices. Trop. J. Pharm. Res., 8(5) : .
Feng H,Zhang L,Zhu C .2013 .Genipin crosslinked ethyl cellulose-chitosan complex microspheres for antituberculosis delivery. Colloids Surf. B. Biointerfaces, 103(2) : 530-537.
Gowda D,Ravi V,Shivakumar H,Hatna S H .2009 .Preparation, evaluation and bioavailability studies of indomethacin-bees wax microspheres. J. Mater. Sci. Mater, 20(7) : 1447-1456.
Gupta NV,Gowda D,Balamuralidhara V,Khan SM .2011 .Formulation and evaluation of olanzapine matrix pellets for controlled release. DARU J. Pharm. Sci., 19(4) : 249.
Hamdani J,Moes AJ,Amighi K AJ .2003 .Physical and thermal characterisation of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int. J. Pharm., 260(1) : 47-57.
Jain P,Jain S,Khan MA .2019 .Formulation and evaluation of extended release floating matrix tablet of eperisone hydrochloride by direct compression method. J. Drug Deliv. Ther., 9 : 86-92.
Jimenez A,Fabra M,Talens P,Chiralt A .2010 .Effect of lipid self-association on the microstructure and physical properties of hydroxypropylmethylcellulose edible films containing fatty acids. , 82(3) : 585-593.
Kranz H,Jurgens K,Pinier M,Siepmann J .2009 .Drug release from MCC-and carrageenan-based pellets: Experiment and theory. Eur. J. Pharm. Biopharm., 73(2) : 302-309.
Kunasekaran V,Rajarajan R,Kannan K,Manavalan R K .2012 .Dosage form design and evaluation of Eperisone hydrochloride matrix film coated extended release tablets. Int. J. Pharm. Pharm., 4(2) : 575-581.
Maboos M,Yousuf RI,Shoaib MH,Nasiri I,Hussain T,Ahmed HF,Iffat W .2018 .Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets. Lipids Health Dis., 17(1) : 136.
Mano T,Miyaoka T .1981 .Effects of muscle relaxant EMPP on afferent discharges of muscle spindle in man--an microneurographic analysis (author's transl). , 33(3) : 237-241.
Muschert S,Siepmann F,Leclercq B,Carlin B,Siepmann J .2009 .Prediction of drug release from ethylcellulose coated pellets. J. Control Release, 135(1) : 71-79.
Nasiri MI,Yousuf RI,Shoaib MH,Fayyaz M,Qazi F,Ahmed K F .2016 .Investigation on release of highly water soluble drug from matrix-coated pellets prepared by extrusion-spheronization technique. J. Coat. Technol., 13(2) : 333-344.
Nasiri MI,Yousuf RI,Shoaib MH,Zaheer K,Ali T,Ahmed K,Qazia F,Anwer S F .2019 .Formulation development and characterization of highly watersoluble drug-loaded extended-release pellets prepared by extrusion-spheronization technique. J. Coat. Technol., 16(5) : 1351-1365.
Nish S,Mathew G,Lincy J .2012 .Matrix tablets: An effective way for oral controlled release drug delivery. Iran. J. Pharm. Sci., 8(3) : 165-170.
Podczeck F,Rahman S,Newton J .1999 .Evaluation of a standardised procedure to assess the shape of pellets using image analysis. Int. J. Pharm., 192(2) : 123-138.
Pongjanyakul T,Medlicott NJ,Tucker IG .2004 .Melted glyceryl palmitostearate (GPS) pellets for protein delivery. Int. J. Pharm., 271(1-2) : 53-62.
Pozzi F,Furlani P,Gazzaniga A,Davis S,Wilding I .1994 .The time clock system: A new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control Release, 31(1) : 99-108.
Qazi F,Shoaib MH,Yousuf RI,Qazi TM,Mehmood ZA,Hasan SMF,Pak SMF .2013 .Formulation development and evaluation of diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M. , 26(4) : 653-663.
Rahman MA,Ahuja A,Baboota S,Bali V,Saigal N,Ali J .2009 .Recent advances in pelletization technique for oral drug delivery: A review. Curr. Drug Deliv., 6(1) : 122-129.
Remington ,Williams Lippincott .2000 .OCoLC)1019679546. The Science and Practice of Pharmacy, : .
Roblegg E,Jager E,Hodzic A,Koscher G,Mohr S,Zimmer A,Khinast J .2011 .Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion. Eur. J. Pharm. Biopharm., 79(3) : 635-645.
Guerra Sertini R,FAL Sertini R .2008 .Open experience with a new myrelaxent for low back pain. The J. App. Res., 8(2) : 226-232.
Singh R,Poddar S,Chivate A .2007 .Sintering of wax for controlling release from pellets. AAPS Pharm. Sci. Tech, 8(3) : E175-E183.
Sriamornsak P,Nunthanid J,Luangtana-Anan M,Weerapol Y,Puttipipatkhachorn S Y .2008 .Alginate-based pellets prepared by extrusion/ spheronization: Effect of the amount and type of sodium alginate and calcium salts. Eur. J. Pharm. Biopharm., 69(1) : 274-284.
Thommes M and Kleinebudde P .2006 .Use of κ- carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur. J. Pharm. Biopharm., 63(1) : 59-67.
Zeng WM .2004 .Oral controlled release formulation for highly water-soluble drugs: Drug-sodium alginatexanthan gum-zinc acetate matrix. Drug Dev, 30(5) : 491-495.
0

Citations

0

Downloads

12

Views